Down-regulation of vascular HMGB1 and RAGE expression by n-3 polyunsaturated fatty acids is accompanied by amelioration of chronic vasculopathy of small bowel allografts

Journal of Nutritional Biochemistry

Volumn 23, Issue 10, 2012, Pages 1333-1340

  Wei, Wei ^a,b   Chen, Min ^c   Zhu, Yanfei ^a,b   Wang, Jian ^b   Zhu, Ping ^d   Li, Yousheng ^b   Li, Jieshou ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

^c MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^d NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Chronic allograft vasculopathy; High mobility group box 1; N 3 polyunsaturated fatty acids; Receptor for advanced glycation end products; Small bowel transplantation

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CORN OIL; CYCLOSPORIN A; FISH OIL; HIGH MOBILITY GROUP B1 PROTEIN; OMEGA 3 FATTY ACID; TACROLIMUS;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CHRONIC ALLOGRAFT VASCULOPATHY; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; FATTY ACID BLOOD LEVEL; GRAFT DYSFUNCTION; INTESTINE GRAFT; LOW DRUG DOSE; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SMALL INTESTINE;

ANIMALS; CHRONIC DISEASE; CORN OIL; DOWN-REGULATION; ENDOTHELIAL CELLS; FATTY ACIDS, OMEGA-3; FISH OILS; GRAFT REJECTION; HMGB1 PROTEIN; INTESTINE, SMALL; MALE; RATS; RATS, INBRED LEW; RECEPTORS, IMMUNOLOGIC;

CHICKEN ANEMIA VIRUS; RATTUS; ZEA MAYS;

EID: 84866307420     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.08.002     Document Type: Article

References (51)

1. Abu-Elmagd K.M. Intestinal transplantation for short bowel syndrome and gastrointestinal failure: current consensus, rewarding outcomes, and practical guidelines. Gastroenterology 2006, 130:S132-S137.
2. Ruiz P., Kato T., Tzakis A. Current status of transplantation of the small intestine. Transplantation 2007, 83:1-6.
3. Lee R.G., Nakamura K., Tsamandas A.C., Abu-Elmagd K., Furukawa H., Hutson W.R., et al. Pathology of human intestinal transplantation. Gastroenterology 1996, 110:1820-1834.
4. Iwami D., Zhang Q., Aramaki O., Nonomura K., Shirasugi N., Niimi M. Purified eicosapentaenoic acid induces prolonged survival of cardiac allografts and generates regulatory T cells. Am J Transplant 2009, 9:1294-1307.
5. Yin R., Huang H.R., Zhang J.W., Zhu J.Q., Jing H., Li Z.D. Dietary n-3 fatty acids attenuate cardiac allograft vasculopathy via activating peroxisome proliferator-activated receptor-gamma. Pediatr Transplant 2008, 12:550-556.
6. Wang J.H., Ma H., Wang J., Li Q.R., Li Y.S., Li J.S. Long-term n-3 polyunsaturated fatty acids administration ameliorates arteriosclerosis by modulating T-cell activity in a rat model of small intestine transplantation. Clin Chim Acta 2007, 381:124-130.
7. Ma H., Wang J.H., Wang J., Li Y.H., Li J.H. Fish oil ameliorates the allograft arteriosclerosis of intestine on rats. Pediatr Transplant 2007, 11:173-179.
8. van Beijnum J.R., Buurman W.A., Griffioen A.W. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis 2008, 11:91-99.
9. Clynes R., Moser B., Yan S.F., Ramasamy R., Herold K., Schmidt A.M. Receptor for AGE (RAGE): weaving tangled webs within the inflammatory response. Curr Mol Med 2007, 7:743-751.
10. Goldstein D.R. The identity of innate immune activators in organ transplantation: origins from within or exterior to the host?. Am J Transplant 2007, 7:1692-1694.
11. Huang Y., Yin H., Han J., Huang B., Xu J., Zheng F., et al. Extracellular Hmgb1 functions as an innate immune-mediator implicated in murine cardiac allograft acute rejection. Am J Transplant 2007, 7:799-808.
12. Moser B., Szabolcs M.J., Ankersmit H.J., Lu Y., Qu W., Weinberg A., et al. Blockade of RAGE suppresses alloimmune reactions in vitro and delays allograft rejection in murine heart transplantation. Am J Transplant 2007, 7:293-302.
13. Lisanti M.P., Scherer P.E., Vidugiriene J., Tang Z.L., Hermanowskivosatka A., Tu Y.H., et al. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source - implications for human-disease. J Cell Biol 1994, 126:111-126.
14. Stitt A.W., Burke G.A., Chen F., McMullen C.B.T., Vlassara H. Advanced glycation end-product receptor interactions on microvascular cells occur within caveolin-rich membrane domains. Faseb J 2000, 14:2390-2392.
15. Reddy M.A., Li S.L., Sahar S., Kim Y.S., Xu Z.G., Lanting L., et al. Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells. J Biol Chem 2006, 281:13685-13693.
16. Yaqoob P. The nutritional significance of lipid rafts. Annu Rev Nutr 2009, 29:257-282.
17. Gani O., Sylte I. Molecular recognition of docosahexaenoic acid by peroxisome proliferator-activated receptors and retinoid-X receptor alpha. J Mol Graph Model 2008, 27:217-224.
18. Yamamoto K., Itoh T., Abe D., Shimizu M., Kanda T., Koyama T., et al. Identification of putative metabolites of docosahexaenoic acid as potent PPAR gamma agonists and antidiabetic agents. Bioorg Med Chem Lett 2005, 15:517-522.
19. Itoh T., Murota I., Yoshikai K., Yamada S., Yamamoto K. Synthesis of docosahexaenoic acid derivatives designed as novel PPAR gamma agonists and antidiabetic agents. Bioorg Med Chem 2006, 14:98-108.
20. Li H., Ruan X.Z., Powis S.H., Fernando R., Mon W.Y., Wheeler D.C., et al. EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism. Kidney Int 2005, 67:867-874.
21. Marx N., Duez H., Fruchart J.C., Staels B. Peroxisome proliferator-activated receptors and atherogenesis - regulators of gene expression in vascular cells. Circ Res 2004, 94:1168-1178.
22. Marx N., Walcher D., Ivanova N., Rautzenberg K., Jung A., Friedl R., et al. Thiazolidinediones reduces endothelial expression of receptors for advanced glycation end products. Diabetes 2004, 53:2662-2668.
23. Yamagishi S.I., Matsui T., Nakamura K., Takeuchi M., Inoue H. Telmisartan inhibits advanced glycation end products (AGEs)-elicited endothelial cell injury by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation. Protein Pept Lett 2008, 15:850-853.
24. Wang K., Zhou Z.M., Zhang M., Fan L.M., Forudi F., Zhou X.R., et al. Peroxisome proliferator-activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model. J Pharmacol Exp Ther 2006, 317:37-43.
25. Zhu Y., Wei W., Li Y. FK506 treatment in a long-term chronic rejection rat model of small bowel transplantation. Clin Invest Med 2010, 33:E168-173.
26. Wei W., Zhu Y., Wang J., Li Y., Li J. Cyanoacrylate-assisted arterial anastomosis in rat small bowel transplantation. Langenbecks Arch Surg 2010, 395:727-735.
27. Nakao A., Tahara K., Inoue S., Tanaka N., Kobayashi E. Experimental models of small intestinal transplantation in rats: orthotopic versus heterotopic model. Acta Med Okayama 2002, 56:69-74.
28. Adams D.H., Tilney N.L., Collins J.J., Karnovsky M.J. Experimental graft arteriosclerosis. The Lewis-to-F344 allograft model. Transplantation 1992, 53:1115-1119.
29. Harris W.S., von Schacky C. The omega-3 index: a new risk factor for death from coronary heart disease?. Prev Med 2004, 39:212-220.
30. Folch J., Lees M., Stanley G.H.S. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957, 226:497-509.
31. Xu W.M., Xu X.L., Zhou G.H., Wang D.Y., Li C.B. Changes of intramuscular phospholipids and free fatty acids during the processing of Nanjing dry-cured. Food Chem 2008, 110:279-284.
32. Snead M.D., Papapetropoulos A., Carrier G.O., Catravas J.D. Isolation and culture of endothelial cells from the mesenteric vascular bed. Methods Cell Sci 1995, 17:257-262.
33. Schmitz G., Ecker J. The opposing effects of n-3 and n-6 fatty acids. Prog Lipid Res 2008, 47:147-155.
34. Suzuki J., Isobe M., Morishita R., Nagai R. Characteristics of chronic rejection in heart transplantation: important elements of pathogenesis and future treatments. Circ J 2010, 74:233-239.
35. Colvin R.B. Chronic allograft nephropathy. N Engl J Med 2003, 349:2288-2290.
36. Rahmani M., Cruz R.P., Granville D.J., McManus B.M. Allograft vasculopathy versus atherosclerosis. Circ Res 2006, 99:801-815.
37. Caforio A.L.P., Tona F., Fortina A.B., Angelini A., Piaserico S., Gambino A., et al. Immune and nonimmune predictors of cardiac allograft vasculopathy onset and severity: multivariate risk factor analysis and role of immunosuppression. Am J Transplant 2004, 4:962-970.
38. Obhrai J., Goldstein D.R. The role of toll-like receptors in solid organ transplantation. Transplantation 2006, 81:497-502.
39. Dumitriu I.E., Baruah P., Valentinis B., Voll R.E., Herrmann M., Nawroth P.P., et al. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J Immunol 2005, 174:7506-7515.
40. Dumitriu I.E., Bianchi M.E., Bacci M., Manfredi A.A., Rovere-Querini P. The secretion of HMGB1 is required for the migration of maturing dendritic cells. J Leukoc Biol 2007, 81:84-91.
41. Chen Y.L., Akirav E.M., Chen W., Henegariu O., Moser B., Desai D., et al. RAGE ligation affects T cell activation and controls T cell differentiation. J Immunol. 2008, 181:4272-4278.
42. Moser B., Desai D.D., Downie M.P., Chen Y., Yan S.F., Herold K., et al. Receptor for advanced glycation end products expression on T cells contributes to antigen-specific cellular expansion in vivo. J Immunol 2007, 179:8051-8058.
43. Basta G. Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications. Atherosclerosis 2008, 196:9-21.
44. Al-Lamki R.S., Bradley J.R., Pober J.S. Endothelial cells in allograft rejection. Transplantation 2008, 86:1340-1348.
45. Siddiqui R.A., Harvey K.A., Zaloga G.P. Modulation of enzymatic activities by n-3 polyunsaturated fatty acids to support cardiovascular health. J Nutr Biochem 2008, 19:417-437.
46. Li Q.R., Zhang Q., Wang M., Liu F.Z., Zhao S.M., Ma J., et al. Docosahexaenoic acid affects endothelial nitric oxide synthase in caveolae. Arch Biochem Biophys 2007, 466:250-259.
47. Li Q.R., Zhang Q., Wang M., Zhao S.M., Ma J., Luo N., et al. Eicosapentaenoic acid modifies lipid composition in caveolae and induces translocation of endothelial nitric oxide synthase. Biochimie 2007, 89:169-177.
48. Candela P., Gosselet F., Saint-Pol J., Sevin E., Boucau M.C., Boulanger E., et al. Apical-to-basolateral transport of amyloid-beta peptides through blood-brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by P-glycoprotein. J Alzheimers Dis 2010, 22:849-859.
49. Vanden Heuvel J.P., Thompson J.T., Frame S.R., Gillies P.J. Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver×receptor-beta, and retinoid×receptor-alpha. Toxicol Sci 2006, 92:476-489.
50. Lim A.K.H., Manley K.J., Roberts M.A., Fraenkel M.B. Fish oil treatment for kidney transplant recipients: a meta-analysis of randomized controlled trials. Transplantation 2007, 83:831-838.
51. Fritsche K. Important differences exist in the dose-response relationship between diet and immune cell fatty acids in humans and rodents. Lipids 2007, 42:961-979.